Covid vaccination Phase-II: Check if you are eligible to get a shot

If you are above 45 years old and have one of co-morbidities listed by the govt, you could get a coronavirus vaccine in this phase-2 of vaccination drive. Here's the full list of health issues

covid vaccine, coronavirus
A man receives a Bharat Biotech's Covid-19 vaccine called COVAXIN, at a vaccination centre, in New Delhi. Photo: Reuters
BS Web Team New Delhi
2 min read Last Updated : Mar 01 2021 | 12:35 PM IST

Don't want to miss the best from Business Standard?

The second phase of India’s Covid-19 vaccination started on Monday and the Co-WIN portal also started a self-registration process for the 270 million people eligible for these shots. Under this phase, people above 60 years of age – and those over 45 years of age and with co-morbidities – are to be inoculated. The registration portal could be accessed at https://selfregistration.cowin.gov.in/.

The government has issued a list of 20 specified co-morbidities to determine the eligibility of people who can be administered a vaccine shot on priority.

If someone is more than 45 years old and suffers from conditions like diabetes or has suffered a heart attack in the past year, they will be eligible to get a Covid-19 vaccine shot. Here’s the full list of specified co-morbidities:

1. Heart failure with hospital admission in the past one year.

2. Post cardiac transplant/ Left Ventricular Assist Device (LVAD).

3. Significant left ventricular systolic dysfunction (LVEF < 40%). 

4. Moderate or severe valvular heart disease. 

5. Congenital heart disease with severe PAH or Idiopathic PAH. 

6. Coronary artery disease with past CABG/ PTCA/ MI And hypertension/diabetes on treatment. 

7. Angina and hypertension/ diabetes treatment. 

8. CT/MRI documented stroke and hypertension/diabetes on treatment. 

9. Pulmonary artery hypertension and hypertension/diabetes on treatment 

10. Diabetes (>10 years or with complication) and hypertension on treatment

11. Kidney/Liver/Hematopoietic stem cell transplant: Recipient/on wait-list

12. End stage kidney disease on haemodialysis/CAPD

13. Current prolonged use of oral corticosteroids/immunosuppressant medications.

14. Decompensated cirrhosis.

15. Severe respiratory disease with hospitalisations in last two years/ FEVI <50%.

16. Lymphoma/Leukaemia/Myeloma

17. Diagnosis of any solid cancer on or after July 1,2020 OR currently on any cancer therapy.

18. Sickle Cell Disease/Bone marrow failure/Aplastic Anemia/Thalassemia Major

19. Primary Immunodeficiency Diseases/HIV infection

20. Persons with disabilities due to intellectual disabilities/muscular dystrophy/acid attack with involvement of respiratory system/Persons with disabilities having high support needs/multiple disabilities including deaf-blindness.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownCoronavirus VaccineBharat BiotechAstraZenecaOxford UniversityWorld Health Organization

Next Story